Panel Discussion | Who Should Get Embolic Protection Device During TAVR?

Monday, March 10, 2025

1:30 PM – 1:45 PM ET

Panel Moderator(s)

Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Neel Butala, MD

Medical Director of Structural Heart Disease and Intervention
Rocky Mountain Regional VA Medical Center

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)
Michael G. Dwyer, PhD

Associate Professor of Neurology and Biomedical Informatics
University at Buffalo
Buffalo, New York, United States

Disclosure(s): ArchCath, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Bristol Meyers Squibb: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Protembis GmbH: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC: No financial relationships to disclose

Axel Linke, MD: Abbott Cardiovascular Systems: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corvia Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Daiichi Sankyo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Filterlex Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); MSD: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis Pharmaceuticals: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transverse Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Neel Butala, MD: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

David J. Cohen, MD, FSCAI: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)

Michael G. Dwyer, PhD: ArchCath, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Bristol Meyers Squibb: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Protembis GmbH: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)